Archiv der Kategorie ‘Amgen‘

Amgen Drug Delays Ovarian Cancer Re Growth, Survival Benefit Unclear

Wednesday, den 12. June 2013

Amgen steigert dank Steuereffekten Gewinn im ersten Quartal deutlich

Tuesday, den 23. April 2013

Amgen to Pay $24.9 Million to Settle U.S. Allegations of Kickbacks

Wednesday, den 17. April 2013

Amgen to Pay $24.9 Million to Settle Kickbacks Allegations

Wednesday, den 17. April 2013

Amgen to pay $25 million to settle kickback allegations

Wednesday, den 17. April 2013

Amgen halten – New Analyst Rating from Independent Research GmbH

Thursday, den 4. April 2013

Independent senkt Amgen auf Halten Ziel hoch auf 115 US Dollar

Wednesday, den 3. April 2013

Amgen halten – New Analyst Rating from Independent Research GmbH

Wednesday, den 3. April 2013

Health Cares Sweet 16 Stocks: Gilead vs. Amgen

Monday, den 1. April 2013

Amgens Future Is Brighter Than You Might Think

Monday, den 18. February 2013

Amgen kaufen – New Analyst Rating from Independent Research GmbH

Monday, den 18. February 2013

Amgen kaufen – New Analyst Rating from Independent Research GmbH

Friday, den 15. February 2013

Has Amgen Become the Perfect Stock?

Monday, den 11. February 2013

Amgen erhoeht wegen Steuereffekt Gewinn-Prognose 2013 leicht

Thursday, den 7. February 2013

Amgen (AMGN) Upgrade from Hold to Buy – Analyst rating from Argus

Friday, den 25. January 2013

Amgen neutral – New Analyst Rating from Goldman Sachs Group Inc.

Friday, den 14. December 2012

Amgen outperform – New Analyst Rating from Credit Suisse Group

Tuesday, den 6. November 2012

Amgen outperform – New Analyst Rating from RBC Capital Markets

Friday, den 5. October 2012

Amgen neutral – New Analyst Rating from Robert W. Baird & Co. Incorporated

Thursday, den 13. September 2012

Amgen neutral – New Analyst Rating from Robert W. Baird & Co. Incorporated

Wednesday, den 12. September 2012

Amgen (AMGN) Upgrade from Neutral to Buy – Analyst rating from UBS

Monday, den 10. September 2012

Amgen buy – New Analyst Rating from UBS AG

Monday, den 10. September 2012

Amgen outperform – New Analyst Rating from RBC Capital Markets

Monday, den 3. September 2012

Amgen outperform – New Analyst Rating from RBC Capital Markets

Friday, den 31. August 2012

Amgen (AMGN) Downgrade from Buy to Hold – Analyst rating from Argus

Thursday, den 2. August 2012

Amgen halten – New Analyst Rating from Independent Research GmbH

Thursday, den 2. August 2012

Amgen outperform – New Analyst Rating from RBC Capital Markets

Thursday, den 5. July 2012

Amgen outperform – New Analyst Rating from RBC Capital Markets

Wednesday, den 4. July 2012

Amgen halten – New Analyst Rating from Der Aktionaer

Friday, den 29. June 2012

Amgen neutral – New Analyst Rating from UBS AG

Thursday, den 26. April 2012

Amgen equal-weight – New Analyst Rating from Barclays Capital

Thursday, den 26. April 2012

Amgen halten – New Analyst Rating from Independent Research GmbH

Thursday, den 26. April 2012

Bayer weitet Kooperation mit Amgen bei Antikoerpern aus

Tuesday, den 24. April 2012

Amgen neutral – New Analyst Rating from Sarasin Research

Wednesday, den 28. March 2012

Amgen kaufen – New Analyst Rating from Die Actien-Boerse

Thursday, den 22. March 2012

Amgen kaufen – New Analyst Rating from Die Actien-Boerse

Wednesday, den 21. March 2012

Amgen hold – New Analyst Rating from Stifel, Nicolaus & Co., Inc.

Friday, den 16. March 2012

Amgen perform – New Analyst Rating from Oppenheimer & Co. Inc.

Friday, den 10. February 2012

Amgen (AMGN) Downgrade from Outperform to Perform – Analyst rating from Oppenheimer

Thursday, den 9. February 2012

Amgen perform – New Analyst Rating from Oppenheimer & Co. Inc.

Thursday, den 9. February 2012

Amgen ( AMGN ) Downgrade from Outperform to Perform – Analyst rating from Oppenheimer

Thursday, den 9. February 2012

Amgen verkaufen – New Analyst Rating from Hamburger Sparkasse AG (Haspa)

Wednesday, den 1. February 2012

Amgen halten – New Analyst Rating from Independent Research GmbH

Monday, den 30. January 2012

Amgen buy – New Analyst Rating from Jefferies & Company Inc.

Wednesday, den 25. January 2012

Amgen hold – New Analyst Rating from Deutsche Bank Securities

Tuesday, den 24. January 2012